483 related articles for article (PubMed ID: 22691758)
1. Therapies in Parkinson's disease.
Jankovic J; Poewe W
Curr Opin Neurol; 2012 Aug; 25(4):433-47. PubMed ID: 22691758
[TBL] [Abstract][Full Text] [Related]
2. Milestones in Parkinson's disease therapeutics.
Rascol O; Lozano A; Stern M; Poewe W
Mov Disord; 2011 May; 26(6):1072-82. PubMed ID: 21626552
[TBL] [Abstract][Full Text] [Related]
3. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
Diaz NL; Waters CH
Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
[TBL] [Abstract][Full Text] [Related]
5. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
6. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
Fox SH; Katzenschlager R; Lim SY; Ravina B; Seppi K; Coelho M; Poewe W; Rascol O; Goetz CG; Sampaio C
Mov Disord; 2011 Oct; 26 Suppl 3():S2-41. PubMed ID: 22021173
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
Henchcliffe C; Schumacher HC; Burgut FT
Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations.
Bhidayasiri R; Ling H
J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256
[TBL] [Abstract][Full Text] [Related]
9. An update on the treatment of Parkinson's disease.
Jankovic J
Mt Sinai J Med; 2006 Jul; 73(4):682-9. PubMed ID: 16878274
[TBL] [Abstract][Full Text] [Related]
10. Treatments for Parkinson disease--past achievements and current clinical needs.
Poewe W
Neurology; 2009 Feb; 72(7 Suppl):S65-73. PubMed ID: 19221317
[TBL] [Abstract][Full Text] [Related]
11. New considerations in the medical management of early Parkinson's disease: impact of recent clinical trials on treatment strategy.
Hauser RA
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S17-21. PubMed ID: 20082983
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: diagnosis and treatment.
Rao SS; Hofmann LA; Shakil A
Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment.
Chen JJ
Am J Manag Care; 2010 Mar; 16 Suppl Implications():S87-93. PubMed ID: 20297871
[TBL] [Abstract][Full Text] [Related]
15. Management of Parkinson's disease a review of current and new therapies.
Mendis T; Suchowersky O; Lang A; Gauthier S
Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
[TBL] [Abstract][Full Text] [Related]
16. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
17. Early pharmacologic treatment in Parkinson's disease.
Hauser RA
Am J Manag Care; 2010 Mar; 16 Suppl Implications():S100-7. PubMed ID: 20297870
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapies for Parkinson's disease.
Poewe W; Mahlknecht P; Jankovic J
Curr Opin Neurol; 2012 Aug; 25(4):448-59. PubMed ID: 22772874
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Chen JJ; Swope DM; Dashtipour K
Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease therapy: treatment of early and late disease.
Jankovic J
Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
